NCT01905137 - Botulinum Toxin Type A Versus Saline Trigger Point Injections for Myofascial Pelvic Pain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

March 9, 2018

Study Completion Date

June 30, 2019

Conditions

Myofascial Pelvic Pain

Interventions

DRUG

Intervention-Botulinum Toxin Type A

Patients will receive 200 units of Botulinum Toxin A diluted in 20 mL of preservative free saline to their pelvic floor followed by pelvic floor physical therapy.

DRUG

placebo

Trial Locations (1)

02138

Boston Urogynecology Associates, Cambridge